Blaize Sets Dec 1 Vote on 1:10–1:35 Reverse Split to Cure Nasdaq Deficiency
BZAI is trading near its 52-week low of $0.172 (11% above the low) on light trading volume (0.3× avg).
Summary
Blaize's definitive proxy sets a December 1, 2026 shareholder vote on a reverse split of 1-for-10 to 1-for-35 to cure its Nasdaq minimum-bid deficiency, alongside a retried director-removal amendment and auditor ratification. Authorized shares stay at 600 million, so the split would leave a large pool of unissued stock available for future issuance.
Key Events · Corporate Governance and Compliance · BZAI
-
Reverse Split Put to December 1 Vote
Shareholders vote December 1, 2026 on a 1-for-10 to 1-for-35 reverse split, with the exact ratio left to the board's discretion within that range.
-
Nasdaq Deadline Is March 29, 2027
Nasdaq notified the company on September 28, 2026 that its bid closed below $1.00 for 30 consecutive days; the company has 180 days, until March 29, 2027, to regain compliance, with a possible second 180-day period via a transfer to the Nasdaq Capital Market.
-
Authorized Shares Stay at 600 Million
The split does not reduce the 600 million authorized shares, so outstanding stock falls to roughly 14,501,342 shares at 1:10 or about 4,143,240 at 1:35 — leaving a large pool of unissued authorized stock available for future issuance.
-
Series B Preferred Skews the Vote
Each one-thousandth of a Series B share carries 1,000 votes and is automatically redeemed if the holder is not present or represented at the meeting, so the reverse split could be approved by holders of less than a majority of outstanding common stock.
Analysis · BZAI · Manufacturing
The headline is a reverse split, but the mechanics are what matter. On December 1, shareholders will be asked to give the board authority for a split of anywhere from 1-for-10 to 1-for-35 — the standard remedy after Nasdaq notified the company on September 28, 2026 that its bid had closed below $1.00 for 30 straight days. Blaize has until March 29, 2027 to regain compliance, and the board says it will not split if the stock closes at or above $1.00 for 10 consecutive trading days first. Authorized shares stay at 600 million while the outstanding count collapses to roughly 14.5 million at 1:10 (or about 4.1 million at 1:35), so the split effectively creates a large pool of unissued authorized stock — room the company can use to raise capital, which cuts both ways for existing holders. The Series B preferred dividend is a structural device: each share carries 1,000,000 votes and is automatically redeemed if the holder does not show up, so shareholders who actually vote effectively carry outsized weight and the reverse split could pass with less than a majority of common shares outstanding. Two other items are on the ballot — a director-removal amendment that failed at the December 3, 2025 annual meeting and is being retried, and ratification of UHY LLP — but neither changes the thesis. The real question is whether the split restores the listing before the March 29, 2027 deadline, against a backdrop of a going-concern warning, a DOJ and SEC investigation, and Q3 revenue of just $0.5 million.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BZAI was trading at $0.19 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $28M. The 52-week trading range was $0.17 to $4.16. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.